In Sherley v. Sebelius, (D DC, July 27, 2011), the federal district court for the District of Columbia upheld the legality of the Obama administration NIH Guidelines for Human Stem Cell Research. The court was constrained by a previous D.C. Circuit Court of Appeals decision that denied a preliminary injunction against implementation of the the Guidelines on the ground that plaintiffs had not shown that they were likely to succeed on the merits. In yesterday's decision, the district court held that plaintiffs have standing to challenge the Guidelines. On the merits, however, the court held that the Guidelines do not violate provisions of the Dickey-Wicker Amendment that prohibit the NIH from funding "research in which a human embryo or embryos are destroyed, discarded, or knowingly subjected to risk of injury or death greater than that allowed for research on fetuses in utero..."
The D.C. Circuit had already determined that the term "research" in the Congressional funding ban was ambiguous. Following the lead of the D.C. Circuit, the district court held that NIH reasonably interpreted the Dickey-Wicker Amendment to allow funding of stem cell research. Finally, the court rejected plaintiffs' claim that the NIH Guidelines were promulgated in violation of the Administrative Procedure Act. Jurist and USA Today report on the decision.
